FDA reaffirms much-criticized plan to regulate genetically engineered animals as if they were a drug

FDA Commissioner Dr. Scott Gottlieb has doubled down on his agency’s failed policy for regulating an entire sector of biotechnology — the ...
dementia x

Small patient pool in Alzheimer’s drug trial casts shadow on positive results

Facing pressing questions about its latest clinical trial in Alzheimer’s disease, Biogen may have sowed further doubt on the future ...

Promising flu drug could be hampered by rapid viral resistance

A new, fast-acting flu drug showed strong potential but also some surprising and even concerning results in two newly published ...

Investigational Alzheimer’s drug shows promise

An investigational Alzheimer’s drug significantly slowed patients’ cognitive decline in a large clinical trial, unexpected and unprecedented results that could ...
Screen Shot at PM

Why Americans respond to drug placebos more than any other nationality

Remarkably the placebo effect--a fake treatment in which a person taking an inactive substance like sugar, water or saline solution ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists